BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28364214)

  • 21. Relationship between frailty and mortality after gastrectomy in older patients with gastric cancer.
    Jeong JR; Choi JW; Ryu SY; Choe YR
    J Geriatr Oncol; 2022 Jan; 13(1):67-73. PubMed ID: 34272203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two frailty indices in the physicians' health study.
    Orkaby AR; Hshieh TT; Gaziano JM; Djousse L; Driver JA
    Arch Gerontol Geriatr; 2017 Jul; 71():21-27. PubMed ID: 28242579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frailty index associated with all-cause mortality, long-term institutionalization, and hip fracture.
    Kim YP; Choe YR; Park JH; Kim S; Won CW; Hwang HS
    Eur Geriatr Med; 2019 Jun; 10(3):403-411. PubMed ID: 34652803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frailty, transition in frailty status and all-cause mortality in older adults of a Taichung community-based population.
    Wang MC; Li TC; Li CI; Liu CS; Lin WY; Lin CH; Yang CW; Yang SY; Lin CC
    BMC Geriatr; 2019 Jan; 19(1):26. PubMed ID: 30691410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between frailty and nutritional status on mortality and long-term hospitalization in older Koreans: A retrospective analysis of data from the 2008 Survey on Health and Welfare Status of the Elderly in Korea.
    Choe YR; Joh JY; Sunwoo D; Kim YP
    Arch Gerontol Geriatr; 2018; 76():106-113. PubMed ID: 29486379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ability of three different models of frailty to predict all-cause mortality: results from the European Male Aging Study (EMAS).
    Ravindrarajah R; Lee DM; Pye SR; Gielen E; Boonen S; Vanderschueren D; Pendleton N; Finn JD; Tajar A; O'Connell MD; Rockwood K; Bartfai G; Casanueva FF; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC; O'Neill TW;
    Arch Gerontol Geriatr; 2013; 57(3):360-8. PubMed ID: 23871598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systolic Blood Pressure and Mortality in Community-Dwelling Older Adults: Frailty as an Effect Modifier.
    Kremer KM; Braisch U; Rothenbacher D; Denkinger M; Dallmeier D;
    Hypertension; 2022 Jan; 79(1):24-32. PubMed ID: 34689594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of frailty in predicting mortality and readmission in older adults in acute care wards: a prospective study.
    Hao Q; Zhou L; Dong B; Yang M; Dong B; Weil Y
    Sci Rep; 2019 Feb; 9(1):1207. PubMed ID: 30718784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frailty Before Critical Illness and Mortality for Elderly Medicare Beneficiaries.
    Hope AA; Gong MN; Guerra C; Wunsch H
    J Am Geriatr Soc; 2015 Jun; 63(6):1121-8. PubMed ID: 26096386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frailty Phenotype and Cause-Specific Mortality in the United States.
    Lohman MC; Sonnega AJ; Resciniti NV; Leggett AN
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(10):1935-1942. PubMed ID: 31956891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do first impressions count? Frailty judged by initial clinical impression predicts medium-term mortality in vascular surgical patients.
    O'Neill BR; Batterham AM; Hollingsworth AC; Durrand JW; Danjoux GR
    Anaesthesia; 2016 Jun; 71(6):684-91. PubMed ID: 27018374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival Outcomes in Older Women with Oestrogen-Receptor-Positive Early-Stage Breast Cancer: Primary Endocrine Therapy vs. Surgery by Comorbidity and Frailty Levels.
    Wang Y; Steinke D; Gavan SP; Chen TC; Carr MJ; Ashcroft DM; Cheung KL; Chen LC
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study.
    Ji J; Sun CL; Cohen HJ; Synold T; Muss H; Sedrak MS
    J Clin Oncol; 2023 Jan; 41(2):307-315. PubMed ID: 36126235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.
    Vidán MT; Blaya-Novakova V; Sánchez E; Ortiz J; Serra-Rexach JA; Bueno H
    Eur J Heart Fail; 2016 Jul; 18(7):869-75. PubMed ID: 27072307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans.
    Patel BG; Luo S; Wildes TM; Sanfilippo KM
    JCO Clin Cancer Inform; 2020 Feb; 4():117-127. PubMed ID: 32083955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frailty in older men: prevalence, progression, and relationship with mortality.
    Cawthon PM; Marshall LM; Michael Y; Dam TT; Ensrud KE; Barrett-Connor E; Orwoll ES;
    J Am Geriatr Soc; 2007 Aug; 55(8):1216-23. PubMed ID: 17661960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frailty Status Predicts All-Cause and Cause-Specific Mortality in Community Dwelling Older Adults.
    Grabovac I; Haider S; Mogg C; Majewska B; Drgac D; Oberndorfer M; Dorner TE
    J Am Med Dir Assoc; 2019 Oct; 20(10):1230-1235.e2. PubMed ID: 31351859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of frailty on 5-year survival in patients older than 70 years undergoing colorectal surgery for cancer.
    Artiles-Armas M; Roque-Castellano C; Fariña-Castro R; Conde-Martel A; Acosta-Mérida MA; Marchena-Gómez J
    World J Surg Oncol; 2021 Apr; 19(1):106. PubMed ID: 33838668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
    Wildiers H; Tryfonidis K; Dal Lago L; Vuylsteke P; Curigliano G; Waters S; Brouwers B; Altintas S; Touati N; Cardoso F; Brain E
    Lancet Oncol; 2018 Mar; 19(3):323-336. PubMed ID: 29433963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer.
    Narasimhulu DM; McGree ME; Weaver AL; Jatoi A; LeBrasseur NK; Glaser GE; Langstraat CL; Block MS; Kumar A
    Gynecol Oncol; 2020 Sep; 158(3):646-652. PubMed ID: 32518016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.